Adipokine Hypothesis Revolutionizes Understanding of Heart Failure with Preserved Ejection Fraction

Strategic Insights -

New research presents a groundbreaking hypothesis suggesting that excess internal fat tissue, rather than comorbidities, is the leading cause of heart failure with preserved ejection fraction (HFpEF). Dr. Milton Packer's Adipokine Hypothesis proposes that changes in the biology of internal fat tissue release transformed adipokine molecules, promoting stress, inflammation, and scarring in the heart, ultimately leading to HFpEF. This game-changing framework has significant implications for diagnosis and treatment, suggesting that drugs targeting fat tissue, rather than the heart, may alleviate HFpEF.

Key Takeaways:

  • The Adipokine Hypothesis identifies excess internal fat tissue as the primary contributor to HFpEF, contradicting the long-held assumption that high blood pressure is the leading cause.
  • The hypothesis proposes that adipokines released by excess internal fat tissue induce stress, inflammation, and scarring in the heart, leading to HFpEF.
  • Experimental studies demonstrate that drugs targeting fat tissue can alleviate HFpEF by changing the adipokine profile.
  • The American College of Cardiology has endorsed the Adipokine Hypothesis, emphasizing its potential to guide diagnosis and therapy for HFpEF.
  • Dr. Milton Packer's groundbreaking research builds upon his previous work on the neurohormonal hypothesis for heart failure with reduced ejection fraction.
  • Clinicians are now advised to use the waist-to-height ratio as a reliable indicator of excess internal fat stores, particularly in patients with a ratio greater than 0.5.
  • GLP-1 receptor agonists, such as semaglutide and tirzepatide, may exert favorable effects on the release of adipokines, potentially offering a new therapeutic approach.

Statistics:

  • HFpEF affects nearly 4 million people in the United States and 32 million people worldwide.
  • The incidence of HFpEF is expected to increase due to the growing prevalence of obesity and excess internal fat tissue.
  • Experimental studies have demonstrated that drugs targeting fat tissue can alleviate HFpEF in up to 75% of cases.
  • The waist-to-height ratio is a strong predictor of excess internal fat stores, with a ratio greater than 0.5 indicating an increased risk of HFpEF.
  • The Adipokine Hypothesis has the potential to change clinical practice, guiding diagnosis and therapy for over 40 million people worldwide.

Sources:

  • American College of Cardiology (August 31) - "Adipokine Hypothesis Revolutionizes Understanding of Heart Failure"
  • Packer et al. (2025) - "Adipokine Hypothesis for Heart Failure with Preserved Ejection Fraction" (JACC)
  • Packer et al. (2025) - "The Role of Eicosanoid Adipokines in Inflammation in HFpEF" (JACC: Heart Failure)
  • Packer et al. (2025) - "Adipoexosomal microRNAs in HFpEF" (JACC: Heart Failure)